Rare diseases
Investigational molecules
Locations
Back to Spain682 clinical trials in Santiago De Compostela, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)A study comparing montelukast to placebo for reducing pain in patients with erosive osteoarthritis of the hands
SpainA study comparing datopotamab deruxtecan with durvalumab versus datopotamab deruxtecan alone for patients with PDL1-negative metastatic triple-negative breast cancer
SpainA study testing ASP5541 compared to abiraterone acetate in patients with advanced prostate cancer
SpainA Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse
SpainEvaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa
SpainStudy of trastuzumab deruxtecan with pembrolizumab versus platinum chemotherapy with pembrolizumab for patients with untreated HER2-positive non-small cell lung cancer
SpainA study of LTP001 in combination with standard treatment for adults with pulmonary arterial hypertension
SpainStudy of abrocitinib oral suspension for children aged 2 years and older with moderate to severe atopic dermatitis to evaluate long-term safety and effectiveness
SpainStudy of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer
SpainStudy of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems
SpainLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
SpainTreatment with trastuzumab deruxtecan, capecitabine and bevacizumab for patients with HER2-positive metastatic colorectal cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on respiratory viral infections, including trials for RSV, influenza, and COVID-19 vaccines. Research aims to enhance protection in vulnerable populations, particularly adults over 60.
Multiple trials evaluating both single and combination vaccine approaches for respiratory diseases.
Research targeting cardiovascular health and prevention, with emphasis on innovative treatments for stroke and heart failure. Studies include both therapeutic interventions and preventive measures.
Focus on developing new therapeutic approaches for better patient outcomes.
Advanced clinical investigations in dermatological conditions, particularly focusing on moderate to severe cases of psoriasis and atopic dermatitis.
Trials evaluating novel therapeutic agents for chronic skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
